• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Schering-Plough

Schering-Plough

  1. All
  2. Morningstar Articles
  3. Investing
  4. Research
  1. Contrarian Buying at American Funds

    American's managers have been busy buying unloved large caps.

  2. High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat

    The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.

  3. This Pharma Firm Passes the Test

    Positive trial data for diabetes drug Januvia and strong first-quarter results keep Merck's stock undervalued and its wide moat intact.

  4. Homestead Value

    With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.

  5. Health-Care Investing Alive and Well

    Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.

  6. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

12

©2017 Morningstar Advisor. All right reserved.